<DOC>
	<DOCNO>NCT01543932</DOCNO>
	<brief_summary>Dual antiplatelet therapy Aspirin Clopidogrel least one year essential patient follow acute coronary syndrome ( ACS ) percutaneous coronary intervention ( PCI ) drug elute stent ( ) implantation . Interindividual variability platelet response Clopidogrel report , several mechanism ( intrinsic high platelet reactivity [ PR ] , variability drug metabolism , various drug interaction ) implicate high post-Clopidogrel treatment PR . The investigator aim perform prospective , single-center , investigator-initiated , randomize , study compare platelet inhibition Prasugrel 10 mg/day , Ticagrelor ( 90 mg twice daily ) high-dose 150 mg/day Clopidogrel patient High on-treatment platelet reactivity ( HTPR ) standard dose Clopidogrel . Patients HTPR ( defined area curve-AUC ≥ 450 &gt; 45 Unit ) loss-of-function allele CYP2C19*2 enrol study randomize ( Day 0 ) 1:1:1 ratio , either Clopidogrel 150 mg day Prasugrel 10 mg day Ticagrelor ( 90 mg twice daily ) Day-15 and-30 post randomization .</brief_summary>
	<brief_title>High Clopidogrel Dose Versus Prasugrel Ticagrelor High Reactive Stable Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>patient underwent percutaneous coronary intervention ( PCI ) clopidogrel resistance Platelet reactivity blood test history bleed diathesis chronic oral anticoagulation treatment contraindication antiplatelet therapy PCI coronary artery bypass grafting ( CABG ) &lt; 3 month hemodynamic instability platelet count &lt; 100,000/μl hematocrit &lt; 30 % creatinine clearance &lt; 25 ml/min Patients history stroke contraindication prasugrel administration patient weigh &lt; 60 kg &gt; 75 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>antiplatelet effect</keyword>
	<keyword>prasugrel</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>stable angina</keyword>
</DOC>